| Tag | Content |
|---|
EnhancerAtlas ID | HS139-24072 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr17:74953690-74954600 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| GLIS1 | MA0735.1 | chr17:74954557-74954573 | CCTTCGTGGGGTGTCT | - | 7.03 | | GLIS3 | MA0737.1 | chr17:74954558-74954572 | CTTCGTGGGGTGTC | - | 6.61 | | MEF2B | MA0660.1 | chr17:74954364-74954376 | GCTAAAAATAGT | + | 6.11 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_58541 | chr17:74952857-75007682 | Ly1 | | SE_61576 | chr17:74943882-75004400 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I076957 | chr17 | 74953764 | 74954731 |
|
Enhancer Sequence | CTGGTGTCCT TATCAGAAGA GGACCCGGGG ACACACAGGG AAGAAATCCC TGTGAAGACA 60
GAGGCAGAGA TCAGAGCCAT GCAGCTGCGC CAGCAAACAC TAAGGCCTGC TGGTGACCGC 120
CGGAAGCTGG GAGGGCAAAG ATGGACCCTT CTCTGGCGCC TTCAGAGGGA ATACGGCCCT 180
GCTGGCACCC TGATGCTGGA CTTCTGGCCT CTAGAACTGT GAGGAAATAC GCTCCCGCGG 240
TTTTAAGCCA CAGCCGGTGG TAAGTGACTA TAACAGCCAT GGGAAGCTCA CACAGAAGGG 300
GTCAGACTTC TGCTGCCTTT CAAGATAATA AGAGGCTGAG CCACGCATCC CGAGTCGGGA 360
GGTAAACGGC CCCCTAGCCA GGCCGCTGGC TCCAGCATGC AGCCCGCTTT GTCTTTTCGC 420
AGAAAAGCAA AGTGTTTGCT GAAAAAAGGC ATCGAAGGAA AGAGAACACA GCTCCCCAGG 480
GATGCAGACC AGTCCCTCCG CCCCAAATAA ACACCCACAA CACAGACCTT CAGGGCACCT 540
GGGGTGCAGA ATCCAGGCGC TTACAGCAGG AGAAGGGGGT GGTCCCCAAG CCTGACTTTT 600
CAGGTTGATT CTGCGCTCCT CTGGGACTGG GCCACTCTCC GAGTCAGCCT GAGATCATCT 660
CCCTCTGAGT CTCAGCTAAA AATAGTCCAG GCTCCGACGT CTGCATATAT TTGAATATTG 720
GGCTCAAGAG ACCGTGATTC TGGGGAAACG GTGCAGCTGG TTCCCCCTGA TGTTGGAGCG 780
TGAAGCCAAC AGAGCACGTT CTCCCCATTA AACTCTCAGC TCCCACAGCT GCCCAGGCCT 840
GACCACCAGC GCCTCTTCCT TAGAGACCCT TCGTGGGGTG TCTTCTCCAG TCTGGGGCCC 900
CATGAAGCAG 910
|
